CASP2 and Huntington disease: The finding that levels of both Δtau314 and Casp2 proteins are higher in HD patients than in non-HD individuals, in two distinct HD-affected brain structures, supports the active involvement of Casp2 in Δtau314 production in human subjects, particularly in HD patients.